Uni-Bio Science Group Ltd (UNBSF)
0.004
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Uni-Bio Science Group Shareholders Equity (Quarterly): 40.04M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 40.04M |
| June 30, 2024 | 40.04M |
| December 31, 2023 | 32.91M |
| June 30, 2023 | 28.67M |
| June 30, 2023 | 28.67M |
| December 31, 2022 | 24.92M |
| June 30, 2022 | 23.02M |
| June 30, 2022 | 23.02M |
| December 31, 2021 | 22.35M |
| June 30, 2021 | 25.06M |
| June 30, 2021 | 25.06M |
| December 31, 2020 | 24.43M |
| June 30, 2020 | 29.17M |
| June 30, 2020 | 29.17M |
| December 31, 2019 | 31.00M |
| June 30, 2019 | 32.70M |
| June 30, 2019 | 32.70M |
| December 31, 2018 | 25.76M |
| June 30, 2018 | 37.06M |
| Date | Value |
|---|---|
| June 30, 2018 | 37.06M |
| December 31, 2017 | 43.92M |
| June 30, 2017 | 55.32M |
| December 31, 2016 | 57.55M |
| June 30, 2016 | 62.10M |
| December 31, 2015 | 65.35M |
| June 30, 2015 | 73.17M |
| September 30, 2014 | 76.07M |
| September 30, 2014 | 76.07M |
| March 31, 2014 | 77.10M |
| September 30, 2013 | 91.02M |
| March 31, 2013 | 90.11M |
| September 30, 2012 | 98.92M |
| March 31, 2012 | 98.82M |
| September 30, 2011 | 101.36M |
| March 31, 2011 | 108.90M |
| September 30, 2010 | 124.14M |
| March 31, 2010 | 131.97M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
22.35M
Minimum
Dec 2021
40.04M
Maximum
Jun 2024
28.50M
Average
28.67M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 4.519B |
| HUTCHMED (China) Ltd | 740.08M |
| Pharmaron Beijing Co Ltd | 1.595B |
| Regencell Bioscience Holdings Ltd | 8.219M |
| Prenetics Global Ltd | 188.24M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.37M |
| Total Liabilities (Quarterly) | 22.34M |
| Debt to Equity Ratio | 0.2638 |
| Current Ratio | 2.505 |